Fan Q, Hawe E, Yang J, Burgess B, Bullano M, Mokdad A. Cost outcomes of noninhibitor patients with hemophilia A switching from prophylaxis with factor VIII to emicizumab: a meta-analysis of real-world evidence studies in the United States. Poster presented at the AMCP Nexus 2023; October 16, 2023. Orlando, FL. [abstract] J Manag Care Pharm. 2023 Oct; 29(10-a Suppl):S35.
Danese S, Kamble P, Yang J, Le Moine JG, Khan S, Hawe E, Agboton C, Wang S, Irving PM. Systematic literature review and meta-analysis: real-world mucosal healing in Vedolizumab-treated patients with Crohn's disease. GastroHep. 2022 Feb 16. doi: 10.1155/2022/6975416
Danese S, Kamble P, Yang J, Le Moine JG, Khan S, Hawe E, Agboton C, Wang S, Irving PM. Vedolizumab rates of mucosal healing in Crohn's disease: a systematic literature review and meta-analysis of real-world data. Presented at the 2021 Digestive Disease Week Virtual Conference; May 23, 2021.
Danese S, Pravin K, Yang J, Le Moine J, Khan S, Hawe E. Vedolizumab rate of mucosal healing in Crohn's disease: a systematic literature review and meta-analysis of real-world data. Poster presented at the 2021 Virtual Digestive Disease Week (DDW) Conference; May 21, 2021.